IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,771,632 | -24.3% | 174,646 | -10.0% | 1.69% | -19.8% |
Q2 2023 | $3,662,290 | +392.2% | 194,080 | +0.2% | 2.11% | +353.8% |
Q1 2023 | $744,012 | -24.6% | 193,753 | -2.6% | 0.46% | -28.5% |
Q4 2022 | $986,212 | +16.2% | 198,833 | +12.0% | 0.65% | +9.4% |
Q3 2022 | $849,000 | +6.1% | 177,600 | -0.1% | 0.59% | +11.0% |
Q2 2022 | $800,000 | -5.3% | 177,706 | +0.1% | 0.54% | +16.6% |
Q1 2022 | $845,000 | – | 177,561 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |